Onderneming GTx, Inc. Nasdaq
Aandelen
US40052B2079
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Oncology Therapies
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Breitmeyer
FOU | Founder | 70 | 01-01-97 |
Richard Vincent
DFI | Director of Finance/CFO | 61 | 01-04-17 |
Salim Yazji
CTO | Chief Tech/Sci/R&D Officer | 55 | 17-05-21 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 51 | 28-08-19 |
Pablo Urbaneja
PRN | Corporate Officer/Principal | - | 01-07-21 |
Anita Wiseth
HRO | Human Resources Officer | - | 01-03-21 |
Chase Leavitt
LAW | General Counsel | 42 | 12-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hale
FOU | Founder | 75 | 01-01-97 |
Dan Kisner
BRD | Director/Board Member | 77 | 07-06-19 |
Rosemary Mazanet
BRD | Director/Board Member | 67 | 27-01-21 |
James Breitmeyer
FOU | Founder | 70 | 01-01-97 |
William LaRue
BRD | Director/Board Member | 73 | 01-12-17 |
Michael Carter
BRD | Director/Board Member | 86 | 07-06-19 |
Charles Theuer
BRD | Director/Board Member | 60 | 01-05-18 |
Jill DeSimone
BRD | Director/Board Member | 68 | 03-01-23 |
Robert Wills
BRD | Director/Board Member | 70 | 07-06-19 |
Xin Nakanishi
BRD | Director/Board Member | 62 | 01-11-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 959 645 | 2 686 463 ( 90,77 %) | 0 | 90,77 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,74% | 46,4 mld. | |
-0,97% | 41,75 mld. | |
+48,32% | 41,37 mld. | |
-3,52% | 29,71 mld. | |
+11,12% | 26,01 mld. | |
-19,37% | 19,52 mld. | |
+31,18% | 12,43 mld. | |
+0,39% | 12,18 mld. | |
-0,04% | 12,13 mld. |